Information Provided By:
Fly News Breaks for November 1, 2018
ANTM
Nov 1, 2018 | 09:01 EDT
RBC Capital analyst Frank Morgan raised his price target on Anthem to $318 and kept his Outperform rating after "another beat and raise" quarter in Q3. The analyst says the results reflected the "solid execution across the enterprise, including better-than-expected medical cost performance". Morgan also cites the management's bullish outlook for FY19 that anticipates growth exceeding consensus expectations, with "further runway in 2020" driven by the IngenioRx development staying on track.
News For ANTM From the Last 2 Days
There are no results for your query ANTM
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.